US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

F/m Emerald Life Sciences Innovation ETF

45.33

-0.0435-0.10%

Post-market: 46.020.6925+1.53%19:30 EDT

Volume:1K

Turnover:49.11K

Market Cap:124.97M

PE:- -

High:46.37

Open:45.39

Low:45.33

Close:45.37

52wk High:48.78

52wk Low:27.68

Shares:2.76M

Float Shares:2.76M

Volume Ratio:0.38

T/O Rate:0.04%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

LivaNova Outlook FY Adjusted Free Cash Flow USD 140-160 Million

THOMSON REUTERS

LivaNova - Enters Long-Term Agreement with Thermo Fisher Scientific for Oxygenator Component Supply

THOMSON REUTERS

LivaNova Plc: Announce Agreement with Thermo Fisher Scientific

THOMSON REUTERS

Press Release: LivaNova Reports Second-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance

Travere Therapeutics, Inc. : Jefferies Raises Target Price to $64 from $54

THOMSON REUTERS

Travere Therapeutics (TVTX) Stock Rallies Over 13% After Hours: Here's What Is Going On

Benzinga Earnings

Travere Therapeutics, Inc. : TD Cowen Raises Target Price to $75 from $60

THOMSON REUTERS

Spyre Therapeutics Inc : Jefferies Raises Target Price to $122 from $98

THOMSON REUTERS

Travere Therapeutics, Inc. : Guggenheim Raises Target Price to $75 from $65

THOMSON REUTERS

Wall Street Analysts Are Bullish on Top Healthcare Picks

Spyre Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Travere Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Travere Therapeutics Q2 Product Sales Rise on Filspari Demand

Spyre Therapeutics Q2 Loss Narrower than Expected; Sees Trial Readouts in 2026

Travere Q2 FY26 Net Loss Widens to $34.8 Million; Filspari Net Sales Rise 96% Year-over-Year to $141.1 Million

Press Release: Spyre Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Travere Therapeutics Q2 EPS USD -0.37

THOMSON REUTERS

Guardant Health is Maintained at Overweight by Morgan Stanley

Guardant Health (GH) Filed A Shelf Registration To Keep Future Funding Options Open

Simply Wall St.

ClearPoint Neuro reports Q2 EPS (38c), consensus (29c)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/LFSC/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LFSC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LFSC\",,,,,undefined,":{"symbol":"LFSC","market":"US","secType":"STK","nameCN":"F/m Emerald Life Sciences Innovation ETF","latestPrice":45.3275,"timestamp":1789156800000,"preClose":45.371,"halted":0,"volume":1074,"hourTrading":{"tag":"盘后","latestPrice":46.02,"preClose":45.3275,"latestTime":"19:30 EDT","volume":10,"amount":452.9875,"timestamp":1789169406017,"change":0.6925,"changeRate":0.015278,"amplitude":0},"delay":0,"changeRate":-0.0009587622049327025,"floatShares":2757035,"shares":2757035,"eps":0,"marketStatus":"Market Closed","change":-0.0435,"latestTime":"09-11 16:00:00 EDT","open":45.39,"high":46.37,"low":45.3275,"amount":49106.001516000004,"amplitude":0.022977,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":45.371,"sharesOutstanding":2657035,"nav":45.4,"aum":125169389,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":46.02,"preClose":45.3275,"latestTime":"19:30 EDT","volume":10,"amount":452.9875,"timestamp":1789169406017,"change":0.6925,"changeRate":0.015278,"amplitude":0},"volumeRatio":0.3761557674902608},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LFSC\",,,,,undefined,":{"symbol":"LFSC","floatShares":2757035,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.3761557674902608,"shares":2757035,"dividePrice":0,"high":46.37,"amplitude":0.022977,"preClose":45.371,"low":45.3275,"week52Low":27.6794,"pbRate":"--","week52High":48.78,"institutionHeld":0,"latestPrice":45.3275,"eps":0,"divideRate":0,"volume":1074,"delay":0,"ttmEps":0,"open":45.39,"prevYearClose":36.6147,"prevWeekClose":46.1341,"prevMonthClose":45.79,"prevQuarterClose":45.2033,"fiveDayClose":46.1466,"twentyDayClose":46.8217,"sixtyDayClose":40.4233},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LFSC\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LFSC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LFSC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LFSC\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657510191","title":"LivaNova Outlook FY Adjusted Free Cash Flow USD 140-160 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657510191","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657510191?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:00","pubTimestamp":1785924001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLX8HZ676:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065171402.SGD","LU2065170008.USD","LU2065171311.SGD","BK4082","LIVN","LFSC","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657510022","title":"LivaNova - Enters Long-Term Agreement with Thermo Fisher Scientific for Oxygenator Component Supply","url":"https://stock-news.laohu8.com/highlight/detail?id=2657510022","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657510022?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:00","pubTimestamp":1785924001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLX8HZ676:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0882574055.USD","HRTS","LFSC","LU2360108059.USD","TMED","LU2764262908.HKD","IE00B2B36J28.USD","BK4585","IE00BQXX3D17.EUR","BK4533","LU2125909916.SGD","LU1923622614.USD","LU1989771016.USD","LU2543165471.USD","LU1153585028.USD","LU2065170008.USD","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU0061474960.USD","LU1983299246.USD","LU1623119135.USD","LU1291159041.SGD","LU0345770993.USD","LU1803068623.USD","LIVN","LU0528227936.USD","LU0823416689.USD","LU2468319806.SGD","LU2063271972.USD","LU1712237335.SGD","BK4082","LU2264538146.SGD","GNMX","LU1064131342.USD","LU1720051017.SGD","LU1720051108.HKD","LU1854103824.USD","TMO","LU0011850046.USD","IE00BJJMRZ35.SGD","LU2433249047.HKD","LU2764263039.SGD","LU1633808545.USD","LU2089984988.USD","FMED","LU1057294990.SGD","IE0034235188.USD","IE00B1BXHZ80.USD","LU1988902786.USD","LU1854104046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657013510","title":"LivaNova Plc: Announce Agreement with Thermo Fisher Scientific","url":"https://stock-news.laohu8.com/highlight/detail?id=2657013510","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657013510?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:00","pubTimestamp":1785924001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLX8HZ676:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HRTS","BK4534","GNMX","LU0122379950.USD","LU2298321311.HKD","LU1153585028.USD","LU1854103824.USD","LIVN","IE0002141913.USD","LU1989771016.USD","LU2089984988.USD","LU0316494557.USD","LU1670628061.USD","BK4535","LFSC","LU2764262908.HKD","LU2125909593.SGD","TMED","LU0011850046.USD","LU1720051017.SGD","LU0114720955.EUR","LU0070302665.USD","LU1988902786.USD","IE00BKPKM429.USD","LU2357305700.SGD","LU2092937221.SGD","LU2764263039.SGD","LU1923622291.USD","LU2065169927.USD","IE00BJJMRZ35.SGD","LU0640476718.USD","IE00B4R5TH58.HKD","LU1815333072.USD","IE00BQXX3C00.GBP","IE0034235188.USD","TMO","LU2125909247.SGD","FMED","LU0061474960.USD","LU2112291526.USD","LU2764263203.CNY","LU1623119135.USD","IE00B19Z9505.USD","GB00BDT5M118.USD","LU0528227936.USD","LU2211815571.USD","LU0234572021.USD","LU0882574055.USD","LU0208291251.USD","LU0957791311.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657510573","title":"Press Release: LivaNova Reports Second-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2657510573","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657510573?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:00","pubTimestamp":1785924000,"startTime":"0","endTime":"0","summary":"-- Delivered double-digit reported revenue growth of 10.8%, with constant-currency revenue growth of 9.8%-- Raised full-year 2026 revenue and adjusted diluted earnings per share guidance-- Entered into a long-term agreement with Thermo Fisher Scientific to strengthen oxygenator component supply to expand manufacturing output and satisfy unmet demandGLOUCESTER, England----August 05, 2026--LivaNova PLC , a market-leading medical technology company, today reported results for the second quarter ended June 30, 2026 and raised full-year 2026 guidance.Financial Summary and Highlights--  Second-quarter revenue of $390.6 million increased 10.8% on a reported. basis and 9.8% on a constant-currency basis as compared to the prior-year. --  Second-quarter U.S. GAAP diluted earnings per share of $1.93 and. --  Second-quarter net cash provided by operating activities of $66.6. million and adjusted free cash flow of $45.5 million. --  Raised full-year 2026 revenue growth range by 100 basis points to ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGLO","PMDE","TM","BK4082","BK4585","GXDW","BK4099","JOYT","VGFPF","DECU","LU2065171311.SGD","VOTE","LIVN","FEBU","LU2065170008.USD","03160","LFSC","LU2065169927.USD","LU2065171402.SGD","BK4555","BK4604","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657451663","title":"Travere Therapeutics, Inc. : Jefferies Raises Target Price to $64 from $54","url":"https://stock-news.laohu8.com/highlight/detail?id=2657451663","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657451663?lang=en_us&edition=fundamental","pubTime":"2026-08-05 15:16","pubTimestamp":1785914203,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nFWN442137:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TVTX","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657516665","title":"Travere Therapeutics (TVTX) Stock Rallies Over 13% After Hours: Here's What Is Going On","url":"https://stock-news.laohu8.com/highlight/detail?id=2657516665","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657516665?lang=en_us&edition=fundamental","pubTime":"2026-08-05 15:16","pubTimestamp":1785914176,"startTime":"0","endTime":"0","summary":"Travere Therapeutics shares surged 13.44% after hours as strong revenue growth and FILSPARI sales gains outweighed earnings concerns.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/08/60938354/travere-therapeutics-shares-surge-after-hours-on-revenue-growth","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BETZ","TVTX","ODDZ","RSI","LFSC","BK4139","FFTY","ODDS","BK4150"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657977695","title":"Travere Therapeutics, Inc. : TD Cowen Raises Target Price to $75 from $60","url":"https://stock-news.laohu8.com/highlight/detail?id=2657977695","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657977695?lang=en_us&edition=fundamental","pubTime":"2026-08-05 13:11","pubTimestamp":1785906671,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nFWN4420C0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LFSC","TVTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657959733","title":"Spyre Therapeutics Inc : Jefferies Raises Target Price to $122 from $98","url":"https://stock-news.laohu8.com/highlight/detail?id=2657959733","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657959733?lang=en_us&edition=fundamental","pubTime":"2026-08-05 12:45","pubTimestamp":1785905138,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nFWN442029:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LFSC","BK4139","SYRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657592054","title":"Travere Therapeutics, Inc. : Guggenheim Raises Target Price to $75 from $65","url":"https://stock-news.laohu8.com/highlight/detail?id=2657592054","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657592054?lang=en_us&edition=fundamental","pubTime":"2026-08-05 12:39","pubTimestamp":1785904752,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nFWN44207D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TVTX","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657659121","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2657659121","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657659121?lang=en_us&edition=fundamental","pubTime":"2026-08-05 11:00","pubTimestamp":1785898840,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Illumina (ILMN) and Travere Therapeutics (TVTX) with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-276?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-276?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4548","BK4535","BK4585","GNOM","GNMX","BK4121","BK4534","TVTX","BK4139","LU0128526141.USD","BK4588","LU0029874061.USD","ILMN","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657567255","title":"Spyre Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657567255","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657567255?lang=en_us&edition=fundamental","pubTime":"2026-08-05 05:21","pubTimestamp":1785878482,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummarySpyre Therapeutics IncSYRE.OQreported a quarterly adjusted loss of 36 cents per share for the quarter ended June ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL8N44137O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SYRE","BK4139","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657673535","title":"Travere Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657673535","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657673535?lang=en_us&edition=fundamental","pubTime":"2026-08-05 05:01","pubTimestamp":1785877300,"startTime":"0","endTime":"0","summary":"Travere Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummaryTravere Therapeutics IncTVTX.OQreported quarterly adjusted earnings of 6 cents per share for the quarter ended ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL8N44134F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVTX","LFSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657611015","title":"Travere Therapeutics Q2 Product Sales Rise on Filspari Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2657611015","media":"Reuters","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657611015?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:15","pubTimestamp":1785874544,"startTime":"0","endTime":"0","summary":"Travere Therapeutics Q2 product sales rise on FILSPARI demandOverviewU.S. biopharma's Q2 net product sales rose 70% yr/yr, driven by FILSPARI growthCompany posted a Q2 net loss after a $40 mln inducem","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL1N44113R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","TVTX","RYTM","IBRX","MEDI","LFSC","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657561508","title":"Spyre Therapeutics Q2 Loss Narrower than Expected; Sees Trial Readouts in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2657561508","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657561508?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:14","pubTimestamp":1785874443,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics Q2 loss narrower than expected; sees trial readouts in 2026OverviewUS biotech firm's Q2 net loss and pretax loss were lower than analyst expectationsQ2 results included a $40 mln ga","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL1N44113Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","PVLA","LFSC","RYTM","BK4139","MEDI","SYRE","DSGN","BK4539","BK4505","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657656922","title":"Travere Q2 FY26 Net Loss Widens to $34.8 Million; Filspari Net Sales Rise 96% Year-over-Year to $141.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657656922","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657656922?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:07","pubTimestamp":1785874058,"startTime":"0","endTime":"0","summary":"Travere Q2 FY26 net loss widens to $34.8 million; FILSPARI net sales rise 96% year-over-year to $141.1 millionTravere posted Q2 GAAP net loss of USD 34.8 million, or USD 0.37 per share, versus a loss ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL6hCCl9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","BK4139","TVTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657256955","title":"Press Release: Spyre Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2657256955","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657256955?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:02","pubTimestamp":1785873720,"startTime":"0","endTime":"0","summary":"Announced positive topline induction data for SPY001 and SPY002 from Part A of the Phase 2 SKYLINE trial (\"SKYLINE\"), demonstrating best-in-class efficacy potential and a safety profile consistent wit","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","LFSC","LENZ","IBD","BK4539","SYRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657756677","title":"Travere Therapeutics Q2 EPS USD -0.37","url":"https://stock-news.laohu8.com/highlight/detail?id=2657756677","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657756677?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:01","pubTimestamp":1785873662,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nPLXFF9SQ5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVTX","BK4139","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656556059","title":"Guardant Health is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2656556059","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656556059?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:44","pubTimestamp":1785847440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","FFOX","GDOC","BK4196","BK4585","LU0889565916.HKD","GH","LU0320765992.SGD","BK4588","EKG","GNOM","GNMX","LU0109394709.USD","HELX","BK4551","LFSC","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656753914","title":"Guardant Health (GH) Filed A Shelf Registration To Keep Future Funding Options Open","url":"https://stock-news.laohu8.com/highlight/detail?id=2656753914","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656753914?lang=en_us&edition=fundamental","pubTime":"2026-08-04 15:22","pubTimestamp":1785828122,"startTime":"0","endTime":"0","summary":"Guardant Health filed a universal shelf registration statement, allowing it to issue various securities in the future.\nThe filing gives the company flexibility to raise capital through debt, equity, or hybrid instruments as needed.\nThis development could be used to support future financing, potential acquisitions, or balance sheet adjustments.\n\nGuardant Health, listed as NasdaqGS:GH, now has formal flexibility to raise funds through a range of securities. The stock last closed at $158.83 and...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-filed-a-shelf-registration-to-keep-future","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-filed-a-shelf-registration-to-keep-future","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","HELX","BK4196","BK4585","LFSC","GDOC","LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD","BK4551","FFOX","BK4535","GNOM","PTH","GNMX","EKG","GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656302838","title":"ClearPoint Neuro reports Q2 EPS (38c), consensus (29c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656302838","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656302838?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:40","pubTimestamp":1785789624,"startTime":"0","endTime":"0","summary":"Reports Q2 revenue $10.88M, consensus $12.73M. “Establishing ClearPoint Neuro (CLPT) as the leading neuro cell and gene therapy delivery company ha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/clearpoint-neuro-reports-q2-eps-38c-consensus-29c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/clearpoint-neuro-reports-q2-eps-38c-consensus-29c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","JDOC","SYNB","BK4082","HELX","CNCR","GNOM","WDNA","FBT","IBBQ","CLPT","LFSC","BK4585","TBXU","IDNA","IBB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}